In fact, the authors injected FaDu cells HER2-specific CAR-T cells when combined with a specific oncolytic adenovirus (CAd) encoding the PD-L1-blocking antibody, and IL-12p70 (CAd12_PDL1) produced tumor regression and extended survival in xerograft and orthotopic models [47]. This evidence concerns the gene ERBB2 and neoplasm.